Navigation Links
Microbiology in Medical Technology

Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743

... systems and assays designed to streamline microbiology testing and improve health outcomes for patients at the 108th meeting of the American Society for microbiology (ASM). Magellan subsidiaries, TREK Diagnostic ... and CEO, Robert J. Rosenthal, Ph.D. "Managers of microbiology labs are looking for integrated systems that ...

Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program

... of GeoVax Labs, Inc. She served as Chief of microbiology and Immunology at Emory University's Yerkes ... Center and was an Asa Griggs Candler Professor of microbiology and Immunology at the Emory University School of ... from Swarthmore College and earned her PhD in microbiology from the Massachusetts Institute of Technology. ...

Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia

... said Dr. Donald Low, Head of the Division of microbiology in the Department of Laboratory Medicine and ... by Donald E. Low, M.D., a recognized authority in microbiology and infectious diseases. The conference call ... of Manitoba and his training in Medical microbiology at the University of Toronto. He is a Fellow of ...

CEL SCI Collaborators Demonstrate Novel L.E.A.P.S. Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other Influenzas

... University of Hawaii reported on data at the annual American Society for microbiology in Philadelphia, PA. This data demonstrates that vaccines utilizing its ... as well. Dr. Borthakur, of the University of Hawaii , reported at the microbiology Conference that mouse blood cells taken from L.E.A.P.S. TB immunized mice ...

Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection

... subgroup analysis presented at 19th annual European Congress of Clinical microbiology and Infectious Diseases (ECCMID) meeting in Helsinki , Finland ... in an oral presentation at the 19th annual European Congress of Clinical microbiology and Infectious Diseases (ECCMID) in Helsinki, Finland. (Logo: ...

Study Shows Use of AdvanDx's PNA FISH(TM) Test was Associated with an 82% Reduction in Intensive Care Unit Mortality Rates from Staphylococcus aureus Bloodstream Infections

... necessary for other nucleic acid technologies. PNA FISH tests enable microbiology labs to provide rapid and accurate identification of bloodstream pathogens ... of translation of PNA FSH-generated laboratory data from the clinical microbiology bench to bedside in real time. Therapeutics and Clinical Risk Management ...

BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures

... It is easy to perform and requires less technologist time than traditional microbiology algorithms, which can take two days to generate results. Studies have shown that providing physicians with critical microbiology information earlier will result in decreased mortality, length of stay and ...

Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy

... through an unrestricted educational grant to the American Society for microbiology and Conexus Health. Symposium and Presentation Schedule Monday, ... Chronic Hepatic Insufficiency About ICAAC The American Society for microbiology (ASM) is hosting the 47th Interscience Conference on Antimicrobial Agents ...

Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced

... its efforts: one in Japan (Yakult Central Institute for Microbiological Research) and one in Europe (Yakult Honsha European Research Center for microbiology ESV). Since developing its overseas network in 1964, Yakult has expanded its business to 32 countries and regions. In addition to producing the ...

IBM and EU Partners Create a Better Way to Fight AIDS Virus

... oriented antiretroviral drug resistance database in the world," explained Professor Maurizio Zazzi, EuResist Scientific Coordinator and Professor of microbiology at the University of Siena School of Medicine." The ability to analyze clinical, laboratory and demographic data accumulated over the years ...

BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results

... to help patients who may have difficulty with an oral or inhaled anti-viral medication. In addition, BioCryst is in negotiations with the Division of microbiology and Infectious Diseases (DMID) and the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) to ...

Corgenix, Tulane Announce Award of NIH Grant Extending Hemorrhagic Fever Virus Product Development Program

... potential bioterrorism agents due to their high fatality rate and ease of transmission from person-to-person. Robert Garry, Ph.D., Professor of microbiology and Immunology at the Tulane University School of Medicine and Principle Investigator of the program, added, "We have been very pleased with the ...

Medizone International, Inc. (MZEI.PK): Trials of the AsepticSure Hospital Sterilization System Have Begun

... deaths and serious infections currently plaguing the healthcare system world wide. Dr. Dick Zoutman, an internationally recognized expert in Medical microbiology and hospital infections, is leading these trials. Medizone International's Director of Medical Affairs, Dr. Michael E. Shannon observed, "This is an ...

Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases

... its lead program, torezolid (TR-701), will be presented in an oral session and six poster presentations at the 19th European Congress of Clinical microbiology and Infectious Diseases (ECCMID) meeting in Helsinki, Finland May 16-19. Torezolid is a novel antibiotic that recently completed Phase 2 clinical ...

New Study Shows Probiotic Strain Effective in Boosting Immune Response to Flu Virus

... comprises approximately 70 percent of the body's immune system, a hypothesis supported by the current study. Dr. Gary Huffnagle, a professor of microbiology and immunology at the University of Michigan , who has reviewed the study's findings, said, "Today, people take medicine to achieve symptomatic ...

AdvanDx Launches Fast, 90 Minutes Protocol for All CE-IVD Marked PNA FISH(R) Tests in Europe

... Cost/Benefit and outcomes studies proving clinical utility of faster results About PNA FISH (R) PNA FISH tests enable microbiology labs to provide rapid and accurate identification of bloodstream pathogens directly from positive blood cultures in hours instead of days. Clinical ...

Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009

... integrated research strategy, which combines state-of-the-art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative ...

Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments

... toward moving our research further at a more rapid pace." Dr. Kachlany, founder of Actinobac Biomed and an associate professor of oral biology, microbiology and molecular genetics at UMDNJ-New Jersey Dental School, discovered the agent, Leukotoxin, during the course of his research at the dental school. ...

Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile

... 3. European Centre for Disease Prevention and Control, Emergence of Clostridium difficile-associated disease in North America and Europe, Clinical microbiology and Infectious Diseases, 2006; 12 (Suppl. 6): 2-18 4. HPA: ...

Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program

... in whole or in part with Federal (United States Government) funds from the National Institute of Allergy and Infectious Diseases (NIAID), Division of microbiology and Infectious Diseases (DMID), under contract number HHSN272200800024C. Pursuant to section 507 of P.L. 104-208 and Section 508 of P.L. 105-78, 100% ...

Delcath Adds Dr. Pamela R. Contag to Its Board of Directors

... Dr. Contag was also recognized as one of the "Top 25 Women in Small Business" by Fortune magazine. Dr. Contag received her Ph.D. in microbiology from the University of Minnesota Medical School and completed her postdoctoral training at Stanford University School of Medicine. Dr. Contag is ...

Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin

... integrated research strategy, which combines state-of-the-art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative ...

Parasites That Live Inside Cells Use Loophole to Thwart Immune System

... Md.); Marcela Henao-Tamayo, Randall Basaraba and Ian Orme (Colorado State University, Fort Collins, Co.); Till Konig (Institute of Medical microbiology and Hygiene University Clinic of Freiburg, Germany); Ulrike Schleicher and Christian Bogdan (Immunology and Hygiene University Clinic of Erlangen, ...

Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting

... integrated research strategy, which combines state-of-the-art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative ...

Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA

... Targeting Methionyl-tRNA Synthase (MetRS) -- F1-335: In Vitro Activity of Rx100472 Against Clinically Important Bacteria -- F1-336: Advanced microbiology Study of Rx100472, A Novel Methionyl-tRNA Synthetase (MetRS) inhibitor -- F1-337: In Vivo Efficacy of Rx100472, A Novel Methionyl-tRNA ...

Survey Shows Parents' Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu

... be right up there, but this survey shows us that we still have a lot of educating to do," said Anne Moscona, M.D., professor of pediatrics and of microbiology and immunology, and vice chair of pediatrics for research at Weill Medical College of Cornell University. "As a community, we need to do a better job ...

Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences

... integrated research strategy, which combines state of the art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative ...

Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections

... integrated research strategy, which combines state of the art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative ...

Advaxis, Inc Initiation Coverage Review Issued By Scimitar Equity, LLC

... Inc is developing proprietary Listeria monocytogenes ("Lm") cancer vaccines based on technology developed by Dr. Yvonne Paterson, Professor of microbiology at the University of Pennsylvania and Chairperson of Advaxis' Scientific Advisory Board. Advaxis is developing therapeutic cancer vaccines ...

'Snapshots' of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report

... that cell death has occurred and tissue is beginning to break down," says Petty, professor of Ophthalmology and Visual Sciences, and professor of microbiology and Immunology at the U-M Medical School. "FA serves as a 'spectral-biomarker' for metabolism gone awry, and we can use the results to detect and ...

Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections

... Chemotherapy (2004) 53, Suppl. S2, ii37-ii50. 2. R. Finch (2006) Gram-positive infections: lessons learnt and novel solutions Clinical microbiology and Infection 12 (s8) , 3-8 doi:10.1111/j.1469-0691.2006 3. Su Young Lee, Joseph L. Kuti, David P. Nicolau. Surgical Infections. September ...

AdvanDx Submits Yeast Traffic Light PNA FISH(TM) for FDA 510(k) Clearance for Detection of Candida species in Positive Blood Cultures

... (FISH) assay that uses PNA (peptide nucleic acid) probes to target species specific ribosomal RNA (rRNA) in bacteria and yeast. PNA FISH tests enable microbiology labs to provide rapid and accurate identification of bloodstream pathogens directly from positive blood cultures in hours instead of days. Clinical ...

Amikacin Inhale Shows Promising Results in Phase II Study

... in ICUs is that they have grown increasingly resistant to currently available antibiotics," said Professor Donald Low, Head of the Department of microbiology at the Toronto Medical Laboratories and Mount Sinai Hospital, Toronto, Canada. "A new treatment option such as Amikacin Inhale, which fights ...

Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas

... Health, including National Cancer Institute. The three senior immunobiologists, Drs. Joseph Coggin, Jim Rohrer and Adel Barsoum of the Department of microbiology and Immunology at the University of South Alabama, will collaborate with the primary investigator, Dr. Paul Schwartzenberger, M.D., an SCC ....

Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council

... integrated research strategy, which combines state of the art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative ...

Arpida Provides Further Comments on the Pivotal Phase III Trials

... has been presented at last year's ICAAC and IDSA meetings. Data on ASSIST-2 will be presented at the upcoming 18th European Congress of Clinical microbiology and Infectious Diseases (ECCMID) which takes place in Barcelona, 19-22 April 2008. As reported in November 2006 and July 2007, intravenous ...

Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference

... integrated research strategy, which combines state of the art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative ...

SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases

... SAI ) today announced that it was awarded a contract extension by the National Institute of Allergy and Infectious Diseases' (NIAID) Division of microbiology and Infectious Diseases (DMID), part of the National Institutes of Health, to provide malaria vaccine production and support services. The ...

Seal Shield Launches World's First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control

... computer keyboard and survive as long as 24 hours. Viruses can live on them for one hour or more." A study reported at the American Society for microbiology found that MRSA can survive on computer keyboards for up to 6 weeks. The recent rise in hospital acquired infections, and the lack of an effective ...

Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV

... represents a milestone in treatment for this disease," said Mark Wainberg, MD, director of the McGill AIDS Centre and professor of medicine and microbiology at McGill University. "I commend the companies involved for joining forces to make ATRIPLA, the first complete three-drug regimen in a single ...
Other Contents
(Date:10/22/2014)... 20, 2014  Leading identity analyst firm Acuity Market ... the world,s population will have a chip-based National eID ... . Asia , with its ... for more than 60% of all National eID cards ... -- "The Global National eID Industry Report: ...
(Date:10/18/2014)... patients referred for evaluation of suspected genetic conditions, ... 25 percent, including detection of a number of ... disease, according to a study appearing in ... coincide with the American Society of Human Genetics ... or coding regions of thousands of genes simultaneously ...
(Date:10/17/2014)... Copenhagen have shown for the first time how bacteria ... patients, giving them the opportunity to get tremendous insights ... The study also discovered the bacterial growth in chronic ... or slowed down by the immune cells. The researchers ... helped "suffocate" the bacteria, forcing the bacteria to switch ...
Breaking Biology News(10 mins):Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Whole-exome sequencing shows potential as diagnostic tool 2Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 ... cases in Dallas. But, mental health specialists say overblown fear ... Barack Obama on Friday appointed an Ebola "czar" to oversee ... Dallas nurses who cared for a Liberian man who died ... But the U.S. cases are miniscule in the context of ...
(Date:10/22/2014)... With the Affordable Care Act (ACA) open ... American Institutes for Research (AIR) finds that three out of ... insurance, but 42 percent say they are not likely or ... up for coverage. , The AIR survey found wide gaps ... to calculate correctly how much they owe for a routine ...
(Date:10/22/2014)... 2014 Although there are only 24 hours in ... people who have trouble finding time within their busy schedules for ... long periods of time to get in shape. Here are five ... the go. , Change Up Your Commute , Consider riding ... add some exercise into your daily routine. If you must use ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... only about half as likely as white women to become ... and the racial disparity persists even when donor eggs are ... patients became pregnant after IVF, compared to about 17 percent ... over two years to tease out the impact of race, ...
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter ... officials on Monday officially tightened guidelines for health workers treating ... exposure and use of a respirator at all times. ... issue the tougher rules after two Dallas nurses contracted Ebola ... United States, Liberian national Thomas Eric Duncan. Nina Pham is ...
Breaking Medicine News(10 mins):Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3
Other TagsOther Tags